Respirics

company

About

Respirics is an inhalation drug products company focusing on the development and commercialization of therapeutic products.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$3.40M
Industries
Biotechnology,Developer Platform,Therapeutics
Founded date
Jan 1, 2000
Number Of Employee
1 - 10
Operating Status
Close

Respirics is an inhalation drug products company focusing on the development and commercialization of therapeutic products using the company's proprietary, customizable Acu-Breatheâ„¢ dry powder inhalers (DPIs). The company's strategy is to develop a suite of inhalation products for asthma and COPD, and to enter licensing and co-development programs with large or specialty pharmaceutical companies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.40M
Respirics has raised a total of $3.40M in funding over 2 rounds. Their latest funding was raised on Sep 27, 2005 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 27, 2005 Series A $3.40M 1 Research Triangle Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Respirics is funded by 1 investors. Research Triangle Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Research Triangle Ventures Yes Series A